1
|
McDowell A, Rieu-Werden ML, Atlas SJ, Fields CD, Goldstein RH, Gundersen GD, Haas JS, Higashi RT, Pruitt SL, Silver MI, Tiro JA, Kamineni A. Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix. LGBT Health 2024. [PMID: 38648535 DOI: 10.1089/lgbt.2023.0067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/25/2024] Open
Abstract
Purpose: We examined characteristics of clinicians caring for transgender men and nonbinary (TMNB) individuals and guideline concordance of clinicians' cervical cancer screening recommendations. Methods: Using a survey of clinicians who performed ≥10 cervical cancer screenings in 2019, we studied characteristics of clinicians who do versus do not report caring for TMNB individuals and guideline concordance of screening recommendations for TMNB individuals with a cervix versus cisgender women. Results: In our sample (N = 492), 49.2% reported caring for TMNB individuals, and 25.4% reported performing cervical cancer screening for TMNB individuals with a cervix. Differences in guideline concordance of screening recommendations for TMNB individuals with a cervix versus cisgender women (45.8% vs. 50% concordant) were not statistically significant. Conclusion: Sizable proportions of clinicians cared for and performed cervical cancer screening for TMNB individuals. Research is needed to better understand clinicians' identified knowledge deficits to develop interventions (e.g., clinician trainings) to improve gender-affirming cervical cancer prevention.
Collapse
Affiliation(s)
- Alex McDowell
- Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
| | - Meghan L Rieu-Werden
- Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Steven J Atlas
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
- Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
| | | | - Robert H Goldstein
- Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
| | | | - Jennifer S Haas
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
- Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Robin T Higashi
- Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA
- Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, USA
| | - Sandi L Pruitt
- Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA
- Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, USA
| | - Michelle I Silver
- Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
| | - Jasmin A Tiro
- Department of Public Health Sciences, University of Chicago Biological Sciences Division, Chicago, Illinois, USA
| | - Aruna Kamineni
- Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA
| |
Collapse
|
2
|
Goldstein RH. Never Let a Good Outbreak Go to Waste. NEJM Evid 2024; 3:EVIDe2300357. [PMID: 38411451 DOI: 10.1056/evide2300357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/28/2024]
Abstract
The multinational outbreak of mpox (formerly known as monkeypox) that began in 2022 resulted in more than 90,000 reported cases, over 150 deaths, and - importantly - a coordinated international response to a rapidly spreading infectious disease.1 Because of decades of global preparedness efforts, vaccines and therapeutics for a related orthopox virus (smallpox) were available in many global stockpiles. Few of these medical countermeasures were specifically designed, evaluated, or approved for use against mpox disease, requiring the global scientific community to identify how best to quickly translate what was known into what was needed.
Collapse
|
3
|
Volpicelli FM, Goldstein RH, Nussbaum EZ. Case 28-2023: A 37-Year-Old Man with a Rash. N Engl J Med 2023; 389:1033-1039. [PMID: 37703558 DOI: 10.1056/nejmcpc2211421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 09/15/2023]
Affiliation(s)
- Frank M Volpicelli
- From the Department of Medicine, New York University (NYU) Langone Hospital Brooklyn, and the Department of Medicine, NYU Grossman School of Medicine - both in Brooklyn, NY (F.M.V.); and the Department of Medicine, Massachusetts General Hospital (R.H.G., E.Z.N.), and the Department of Medicine, Harvard Medical School (R.H.G., E.Z.N.) - both in Boston
| | - Robert H Goldstein
- From the Department of Medicine, New York University (NYU) Langone Hospital Brooklyn, and the Department of Medicine, NYU Grossman School of Medicine - both in Brooklyn, NY (F.M.V.); and the Department of Medicine, Massachusetts General Hospital (R.H.G., E.Z.N.), and the Department of Medicine, Harvard Medical School (R.H.G., E.Z.N.) - both in Boston
| | - E Zachary Nussbaum
- From the Department of Medicine, New York University (NYU) Langone Hospital Brooklyn, and the Department of Medicine, NYU Grossman School of Medicine - both in Brooklyn, NY (F.M.V.); and the Department of Medicine, Massachusetts General Hospital (R.H.G., E.Z.N.), and the Department of Medicine, Harvard Medical School (R.H.G., E.Z.N.) - both in Boston
| |
Collapse
|
4
|
Arrington-Sanders R, Connell NT, Coon D, Dowshen N, Goldman AL, Goldstein Z, Grimstad F, Javier NM, Kim E, Murphy M, Poteat T, Radix A, Schwartz A, St Amand C, Streed CG, Tangpricha V, Toribio M, Goldstein RH. Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review. Endocr Pract 2023; 29:272-278. [PMID: 36539066 PMCID: PMC10081942 DOI: 10.1016/j.eprac.2022.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 12/01/2022] [Accepted: 12/10/2022] [Indexed: 12/23/2022]
Abstract
OBJECTIVE Accumulating evidence demonstrates that gender affirming hormone therapy (GAHT) improves mental health outcomes in transgender persons. Data specific to the risks associated with GAHT for transgender persons continue to emerge, allowing for improvements in understanding, predicting, and mitigating adverse outcomes while informing discussion about desired effects. Of particular concern is the risk of venous thromboembolism (VTE) in the context of both longitudinal GAHT and the perioperative setting. Combining what is known about the risk of VTE in cisgender individuals on hormone therapy (HT) with the evidence for transgender persons receiving HT allows for an informed approach to assess underlying risk and improve care in the transgender community. OBSERVATIONS Hormone formulation, dosing, route, and duration of therapy can impact thromboembolic risk, with transdermal estrogen formulations having the lowest risk. There are no existing risk scores for VTE that consider HT as a possible risk factor. Risk assessment for recurrent VTE and bleeding tendencies using current scores may be helpful when assessing individual risk. Gender affirming surgeries present unique perioperative concerns, and certain procedures include a high likelihood that patients will be on exogenous estrogens at the time of surgery, potentially increasing thromboembolic risk. CONCLUSIONS AND RELEVANCE Withholding GAHT due to potential adverse events may cause negative impacts for individual patients. Providers should be knowledgeable about the management of HT in transgender individuals of all ages, as well as in the perioperative setting, to avoid periods in which transgender individuals are off GAHT. Treatment decisions for both anticoagulation and HT should be individualized and tailored to patients' overall goals and desired outcomes, given that the physical and mental health benefits of gender affirming care may outweigh the risk of VTE.
Collapse
Affiliation(s)
- Renata Arrington-Sanders
- Division of Adolescent and Young Adult Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland
| | - Nathan T Connell
- Division of Hematology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
| | - Devin Coon
- Division of Plastic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Departments of Plastic Surgery and Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Nadia Dowshen
- Craig-Dalsimer Division of Adolescent Medicine, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
| | - Anna L Goldman
- Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
| | - Zil Goldstein
- Callen-Lorde Community Health Center, New York, NY; City University of New York Graduate School of Public Health & Health Policy, New York, New York
| | - Frances Grimstad
- Division of Gynecology, Department of Surgery, Boston Children's Hospital, Boston, Massachusetts; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, Massachusetts
| | - Noelle Marie Javier
- Associate Professor, Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Ellie Kim
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
| | - Martina Murphy
- Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida
| | - Tonia Poteat
- Associate Professor of Social Medicine, Center for Health Equity Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina
| | - Asa Radix
- Callen-Lorde Community Health Center, New York, New York
| | - Aviva Schwartz
- North American Thrombosis Forum, Brookline, Massachusetts
| | - Colt St Amand
- Department of Psychology, University of Houston, Houston, Texas; Department of Family Medicine, Mayo Clinic, Rochester, Minnesota
| | - Carl G Streed
- Assistant Professor of Medicine, Section of General Internal Medicine, Boston University Chobanian & Avedisian School of Medicine Center for Transgender Medicine and Surgery, Boston Medical Center, Boston, Massachusetts
| | - Vin Tangpricha
- Division of Endocrinology, Metabolism & Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA and the Atlanta VA Medical Center, Decatur, Georgia
| | - Mabel Toribio
- Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
| | - Robert H Goldstein
- Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
| |
Collapse
|
5
|
Fakih R, Goldstein RH, Kozlov G, Gehring K. Burst kinetics and CNNM binding are evolutionarily conserved properties of phosphatases of regenerating liver. J Biol Chem 2023; 299:103055. [PMID: 36822330 PMCID: PMC10040874 DOI: 10.1016/j.jbc.2023.103055] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Revised: 02/17/2023] [Accepted: 02/18/2023] [Indexed: 02/25/2023] Open
Abstract
Phosphatases of regenerating liver (PRL or PTP4A) are a family of enigmatic protein phosphatases implicated in cell growth and metabolism. Despite their relevance in metastatic cancer, much remains unknown about the PRL family. They act as pseudophosphatases to regulate the CNNM family of magnesium transporters yet also have enzymatic activity on unknown substrates. In mammals, PRLs are mostly found trapped in an intermediate state that regulates their pseudophosphatase activity. Phosphocysteine, which is formed as an intermediate in the phosphatase catalytic cycle, is inefficiently hydrolyzed leading to burst enzyme kinetics and turnover numbers of less than one per hour. In flies, PRLs have recently been shown to have neuroprotective and neurodevelopmental roles raising the question whether they act as phosphatases, pseudophosphatases, or both. Here, we characterize the evolutionary development of PRLs and ask whether their unique structural and functional properties are conserved. We purified recombinant PRL proteins from 15 phylogenetically diverse organisms and characterized their catalytic activities and ability to bind CNNM proteins. We observed PRLs from humans to amoebae form a stable phosphocysteine intermediate and exhibit burst kinetics. Isothermal titration calorimetry experiments confirmed that the PRL-CNNM interaction is broadly conserved with nanomolar affinity in vertebrates. Lastly, we determined the crystal structure of the Drosophila melanogaster PRL-CNNM complex and identified mutants that specifically impair either phosphatase activity or CNNM binding. Our results reveal the unique properties of PRLs are conserved throughout the animal kingdom and open the door to using model organisms to dissect PRL function in cell signaling.
Collapse
Affiliation(s)
- Rayan Fakih
- Department of Biochemistry, Centre for Structural Biology, McGill University, Montreal, Quebec, Canada
| | - Robert H Goldstein
- Department of Biochemistry, Centre for Structural Biology, McGill University, Montreal, Quebec, Canada
| | - Guennadi Kozlov
- Department of Biochemistry, Centre for Structural Biology, McGill University, Montreal, Quebec, Canada
| | - Kalle Gehring
- Department of Biochemistry, Centre for Structural Biology, McGill University, Montreal, Quebec, Canada.
| |
Collapse
|
6
|
Person AK, Armstrong WS, Evans T, Fangman JJW, Goldstein RH, Haddad M, Jain MK, Keeshin S, Tookes HE, Weddle AL, Feinberg J. Principles for Ending Human Immunodeficiency Virus as an Epidemic in the United States: A Policy Paper of the Infectious Diseases Society of America and the HIV Medical Association. Clin Infect Dis 2023; 76:1-9. [PMID: 35965395 DOI: 10.1093/cid/ciac626] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2022] [Accepted: 07/27/2022] [Indexed: 01/26/2023] Open
Abstract
While we have the tools to achieve this goal, the persistent barriers to healthcare services experienced by too many individuals will need to be addressed to make significant progress and improve the health and quality of life of all people with human immunodeficiency virus (HIV). The necessary structural changes require actions by federal, state, and local policymakers and range from ensuring universal access to healthcare services to optimizing care delivery to ensuring a robust and diverse infectious diseases and HIV workforce. In this article, we outlines 10 key principles for policy reforms that, if advanced, would make ending the HIV epidemic in the United States possible and could have much more far-reaching effects in improving the health of our nation.
Collapse
Affiliation(s)
- Anna K Person
- Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA
| | - Wendy S Armstrong
- Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.,Grady Healthcare System, Infectious Diseases Program, Atlanta, Georgia, USA
| | - Tyler Evans
- Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
| | - John J W Fangman
- Mass General Brigham Community Physicians, Boston, Massachusetts, USA
| | - Robert H Goldstein
- Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Marwan Haddad
- Center for Key Populations, Community Health Center, Inc, Middletown, Connecticut, USA
| | - Mamta K Jain
- Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.,Parkland Health and Hospital System, Dallas, Texas, USA
| | - Susana Keeshin
- Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, USA
| | - Hansel E Tookes
- Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Andrea L Weddle
- HIV Medicine Association of the Infectious Diseases Society of America, Arlington, Virginia, USA
| | - Judith Feinberg
- Departments of Behavioral Medicine and Psychiatry and Medicine/Infectious Diseases, West Virginia University School of Medicine, Morgantown, West Virginia, USA
| |
Collapse
|
7
|
Affiliation(s)
- John T Brooks
- From the Multinational Monkeypox Outbreak Response (J.T.B.) and the Office of the Director (R.H.G., R.P.W.), Centers for Disease Control and Prevention, Atlanta; and the Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (P.M.)
| | - Peter Marks
- From the Multinational Monkeypox Outbreak Response (J.T.B.) and the Office of the Director (R.H.G., R.P.W.), Centers for Disease Control and Prevention, Atlanta; and the Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (P.M.)
| | - Robert H Goldstein
- From the Multinational Monkeypox Outbreak Response (J.T.B.) and the Office of the Director (R.H.G., R.P.W.), Centers for Disease Control and Prevention, Atlanta; and the Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (P.M.)
| | - Rochelle P Walensky
- From the Multinational Monkeypox Outbreak Response (J.T.B.) and the Office of the Director (R.H.G., R.P.W.), Centers for Disease Control and Prevention, Atlanta; and the Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (P.M.)
| |
Collapse
|
8
|
Siedner MJ, Boucau J, Gilbert RF, Uddin R, Luu J, Haneuse S, Vyas T, Reynolds Z, Iyer S, Chamberlin GC, Goldstein RH, North CM, Sacks CA, Regan J, Flynn JP, Choudhary MC, Vyas JM, Barczak AK, Lemieux JE, Li JZ. Duration of viral shedding and culture positivity with post-vaccination SARS-CoV-2 delta variant infections. JCI Insight 2021; 7:155483. [PMID: 34871181 PMCID: PMC8855795 DOI: 10.1172/jci.insight.155483] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2021] [Accepted: 12/03/2021] [Indexed: 11/17/2022] Open
Abstract
Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection of nasal swabs for SARS-CoV-2 viral load quantification, whole-genome sequencing, and viral culture. All delta variant infections in our cohort were symptomatic, compared with 64% of non-delta variant infections. Symptomatic delta variant breakthrough infections were characterized by higher initial viral load, longer duration of virologic shedding by PCR, greater likelihood of replication-competent virus at early stages of infection, and longer duration of culturable virus compared with non-delta variants. The duration of time since vaccination was also correlated with both duration of PCR positivity and duration of detection of replication-competent virus. Nonetheless, no individuals with symptomatic delta variant infections had replication-competent virus by day 10 after symptom onset or 24 hours after resolution of symptoms. These data support US CDC isolation guidelines as of November 2021, which recommend isolation for 10 days or until symptom resolution and reinforce the importance of prompt testing and isolation among symptomatic individuals with delta breakthrough infections. Additional data are needed to evaluate these relationships among asymptomatic and more severe delta variant breakthrough infections.
Collapse
Affiliation(s)
- Mark J Siedner
- Massachusetts General Hospital, Boston, United States of America
| | - Julie Boucau
- Ragon Institute of MGH, MIT and Harvard, Cambridge, United States of America
| | - Rebecca F Gilbert
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Rockib Uddin
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Jonathan Luu
- Department of Biostatistics, TH Chan Harvard School of Public Health, Boston, United States of America
| | - Sebastien Haneuse
- Department of Biostatistics, TH Chan Harvard School of Public Health, Boston, United States of America
| | - Tammy Vyas
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Zahra Reynolds
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Surabhi Iyer
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Grace C Chamberlin
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Robert H Goldstein
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Crystal M North
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Chana A Sacks
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - James Regan
- Department of Medicine, Brigham and Women's Hospital, Cambridge, United States of America
| | - James P Flynn
- Department of Medicine, Brigham and Women's Hospital, Cambridge, United States of America
| | - Manish C Choudhary
- Department of Medicine, Brigham and Women's Hospital, Cambridge, United States of America
| | - Jatin M Vyas
- Department of Medicine, Massachusetts General Hospital, Boston, United States of America
| | - Amy K Barczak
- Ragon Institute of MGH, MIT and Harvard, Cambridge, United States of America
| | - Jacob E Lemieux
- Infectious Disease Unit, Massachusetts General Hospital, Boston, United States of America
| | - Jonathan Z Li
- Department of Infectious Disease, Brigham and Women's Hospital, Boston, United States of America
| |
Collapse
|
9
|
Affiliation(s)
- Robert H Goldstein
- From the Departments of Medicine (R.H.G., G.K.R.), Radiology (W.A.M.), and Pathology (B.H.), Massachusetts General Hospital, and the Departments of Medicine (R.H.G., G.K.R.), Radiology (W.A.M.), and Pathology (B.H.), Harvard Medical School - both in Boston
| | - William A Mehan
- From the Departments of Medicine (R.H.G., G.K.R.), Radiology (W.A.M.), and Pathology (B.H.), Massachusetts General Hospital, and the Departments of Medicine (R.H.G., G.K.R.), Radiology (W.A.M.), and Pathology (B.H.), Harvard Medical School - both in Boston
| | - Bailey Hutchison
- From the Departments of Medicine (R.H.G., G.K.R.), Radiology (W.A.M.), and Pathology (B.H.), Massachusetts General Hospital, and the Departments of Medicine (R.H.G., G.K.R.), Radiology (W.A.M.), and Pathology (B.H.), Harvard Medical School - both in Boston
| | - Gregory K Robbins
- From the Departments of Medicine (R.H.G., G.K.R.), Radiology (W.A.M.), and Pathology (B.H.), Massachusetts General Hospital, and the Departments of Medicine (R.H.G., G.K.R.), Radiology (W.A.M.), and Pathology (B.H.), Harvard Medical School - both in Boston
| |
Collapse
|
10
|
North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA. Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19]. Clin Infect Dis 2021; 74:1275-1278. [PMID: 34363462 PMCID: PMC8436402 DOI: 10.1093/cid/ciab643] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Indexed: 01/19/2023] Open
Abstract
The impact of coronavirus disease 2019 vaccination on viral characteristics of breakthrough infections is unknown. In this prospective cohort study, incidence of severe acute respiratory syndrome coronavirus 2 infection decreased following vaccination. Although asymptomatic positive tests were observed following vaccination, the higher cycle thresholds, repeat negative tests, and inability to culture virus raise questions about their clinical significance.
Collapse
Affiliation(s)
- Crystal M North
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Amy Barczak
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA.,The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA
| | - Robert H Goldstein
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Brian C Healy
- Harvard Medical School, Boston, MA, USA.,Department of Biostatistics, Massachusetts General Hospital, Boston, MA, USA
| | | | - Delaney D Ding
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
| | - Andy Kim
- Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Julie Boucau
- The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA
| | - Bennett Shaw
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
| | - Rebecca F Gilbert
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
| | - Tammy Vyas
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
| | - Zahra Reynolds
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
| | | | | | - James Regan
- Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - James P Flynn
- Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Manish C Choudhary
- Harvard Medical School, Boston, MA, USA.,Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Jatin M Vyas
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Karl Laskowski
- Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Anand S Dighe
- Harvard Medical School, Boston, MA, USA.,Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
| | - Jacob E Lemieux
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Jonathan Z Li
- Harvard Medical School, Boston, MA, USA.,Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Lindsey R Baden
- Harvard Medical School, Boston, MA, USA.,Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Mark J Siedner
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Ann E Woolley
- Harvard Medical School, Boston, MA, USA.,Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Chana A Sacks
- Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| |
Collapse
|
11
|
Bunting SR, Garber SS, Goldstein RH, Calabrese SK, Ritchie TD, Batteson TJ. Health Profession Students' Awareness, Knowledge, and Confidence Regarding Preexposure Prophylaxis: Results of a National, Multidisciplinary Survey. Sex Transm Dis 2021; 48:25-31. [PMID: 32810029 DOI: 10.1097/olq.0000000000001263] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
BACKGROUND Preexposure prophylaxis (PrEP) is a highly effective, pharmacologic method of HIV prevention. Despite its safety and efficacy, PrEP prescription remains low in those patients who are at highest risk for HIV infection. One possible reason for this may be the lack of inclusion of PrEP and HIV prevention discussions within the curricula of health professions education. METHODS An online survey was administered to a cross-sectional sample of future prescribers (osteopathic/allopathic medical and physician assistant students), future nurses, and future pharmacists (n = 2085) in the United States between January and July 2019 to assess and compare awareness of PrEP, PrEP education, PrEP knowledge, and confidence in 2 areas related to PrEP. RESULTS We show that, overall, awareness of PrEP is high among future health care providers (81.6%), with the future pharmacists reporting the greatest awareness (92.2%; P < 0.001) and more commonly reporting PrEP education (71.0%). Students had mixed knowledge of PrEP, with future pharmacists reporting the highest knowledge of PrEP. Approximately 30% of students in all disciplines reported having low confidence counseling a patient about PrEP and low confidence educating a colleague about PrEP. Knowledge of PrEP was a significant predictor of confidence counseling a patient about PrEP (P < 0.001) and educating a colleague about PrEP (P < 0.001). CONCLUSIONS This study identifies opportunities to improve and incorporate evidence-based strategies for educating future health care providers about PrEP for HIV prevention within health professions curricula.
Collapse
Affiliation(s)
| | - Sarah S Garber
- Pharmaceutical Sciences, College of Pharmacy, Rosalind Franklin University of Medicine and Science, North Chicago, IL
| | - Robert H Goldstein
- Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
| | - Sarah K Calabrese
- Department of Psychological and Brain Sciences, George Washington University, Washington, DC
| | | | - Tamzin J Batteson
- DeWitt C. Baldwin Institute for Interprofessional Education, Rosalind Franklin University of Medicine and Science, North Chicago, IL
| |
Collapse
|
12
|
Affiliation(s)
- Robert H Goldstein
- Division of Infectious Diseases and Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston
- Harvard Medical School, Boston, Massachusetts
| | - Rochelle P Walensky
- Division of Infectious Diseases, Massachusetts General Hospital, Boston
- Harvard Medical School, Boston, Massachusetts
| |
Collapse
|
13
|
Bunting SR, Garber SS, Goldstein RH, Ritchie TD, Batteson TJ, Keyes TJ. Student Education About Pre-exposure Prophylaxis (PrEP) Varies Between Regions of the United States. J Gen Intern Med 2020; 35:2873-2881. [PMID: 32080792 PMCID: PMC7573046 DOI: 10.1007/s11606-020-05736-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Accepted: 02/10/2020] [Indexed: 01/07/2023]
Abstract
BACKGROUND Daily, oral pre-exposure prophylaxis (PrEP) is an effective and safe prevention strategy for people at risk for HIV. However, prescription of PrEP has been limited for patients at the highest risk. Disparities in PrEP prescription are pronounced among racial and gender minority patients. A significant body of literature indicates that practicing healthcare providers have little awareness and knowledge of PrEP. Very little work has investigated the education about PrEP among health professionals in training. OBJECTIVE The objective of this study was to compare health professions students' awareness of PrEP and education about PrEP between regions of the US, and to determine if correlations between regional HIV incidence and PrEP use were present. DESIGN Survey study. PARTICIPANTS A cross-sectional sample of health professions students (N = 1859) representing future prescribers (MD, DO, PA), pharmacists, and nurses in the US. KEY RESULTS Overall, 83.4% of students were aware of PrEP, but only 62.2% of fourth-year students indicated they had been taught about PrEP at any time during their training. Education about PrEP was most comprehensive in the Northeastern US, the area with the highest PrEP to need ratio (4.7). In all regions, transgender patients and heterosexual men and women were least likely to be presented in education as PrEP candidates, and men who have sex with men were the most frequently presented. CONCLUSIONS There are marked differences in education regarding PrEP both between academic programs and regions of the USA.
Collapse
Affiliation(s)
- Samuel R Bunting
- Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
| | - Sarah S Garber
- Pharmaceutical Sciences, College of Pharmacy, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA
| | - Robert H Goldstein
- Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | | | - Tamzin J Batteson
- DeWitt C. Baldwin Institute for Interprofessional Education, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA
| | | |
Collapse
|
14
|
|
15
|
Affiliation(s)
- Robert H Goldstein
- From the Division of Infectious Diseases, Department of Medicine (R.H.G., R.P.W.), and the Medical Practice Evaluation Center (R.P.W.), Massachusetts General Hospital, and the Harvard University Center for AIDS Research, Harvard Medical School (R.P.W.) - both in Boston
| | - Rochelle P Walensky
- From the Division of Infectious Diseases, Department of Medicine (R.H.G., R.P.W.), and the Medical Practice Evaluation Center (R.P.W.), Massachusetts General Hospital, and the Harvard University Center for AIDS Research, Harvard Medical School (R.P.W.) - both in Boston
| |
Collapse
|
16
|
Affiliation(s)
- Mason W Freeman
- From the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Massachusetts General Hospital, and the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Harvard Medical School - both in Boston
| | - Ajay K Singh
- From the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Massachusetts General Hospital, and the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Harvard Medical School - both in Boston
| | - Amanda C Guidon
- From the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Massachusetts General Hospital, and the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Harvard Medical School - both in Boston
| | - Sheila L Arvikar
- From the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Massachusetts General Hospital, and the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Harvard Medical School - both in Boston
| | - Robert H Goldstein
- From the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Massachusetts General Hospital, and the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Harvard Medical School - both in Boston
| | - Nathan F Clement
- From the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Massachusetts General Hospital, and the Departments of Medicine (M.W.F., S.L.A., R.H.G.), Radiology (A.K.S.), Neurology (A.C.G.), and Pathology (N.F.C.), Harvard Medical School - both in Boston
| |
Collapse
|
17
|
Moussa Y, Sullivan A, Matte G, Goldstein RH, Baldini G, Shuster J, Tsoukas C. Impact of persistent β-lactam allergy documentation despite delabeling in the perioperative setting. J Allergy Clin Immunol Pract 2019; 8:411-412. [PMID: 31295562 DOI: 10.1016/j.jaip.2019.06.029] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/10/2018] [Revised: 06/04/2019] [Accepted: 06/21/2019] [Indexed: 11/16/2022]
Affiliation(s)
- Yara Moussa
- Department of Medicine, Division of Allergy and Clinical Immunology, McGill University, Montreal, QC, Canada; The Research Institute of the McGill University Health Centre, Division of Experimental Medicine, McGill University, Montreal, QC, Canada
| | - Andrew Sullivan
- The Research Institute of the McGill University Health Centre, Division of Experimental Medicine, McGill University, Montreal, QC, Canada
| | - Gilbert Matte
- Department of Pharmacy, McGill University Health Center, Montreal, QC, Canada
| | - Robert H Goldstein
- The Research Institute of the McGill University Health Centre, Division of Experimental Medicine, McGill University, Montreal, QC, Canada
| | - Gabriele Baldini
- Department of Anesthesia, McGill University Health Center, Montreal General Hospital, Montreal, QC, Canada
| | - Joseph Shuster
- Department of Medicine, Division of Allergy and Clinical Immunology, McGill University, Montreal, QC, Canada; The Research Institute of the McGill University Health Centre, Division of Experimental Medicine, McGill University, Montreal, QC, Canada
| | - Christos Tsoukas
- Department of Medicine, Division of Allergy and Clinical Immunology, McGill University, Montreal, QC, Canada; The Research Institute of the McGill University Health Centre, Division of Experimental Medicine, McGill University, Montreal, QC, Canada.
| |
Collapse
|
18
|
Abstract
Merkel cell carcinoma (MCC) is a highly aggressive, primary neuroendocrine cancer of the skin. The majority of MCC cases are associated with the recently discovered Merkel cell polyomavirus (MCPyV), while the remaining are caused by ultraviolet (UV) light-induced mutations from excessive sunlight exposure. The risk of developing MCC is much higher in the white population relative to all other races. Approximately 10% of all patients with MCC have some form of immunosuppression including HIV-1/AIDS, chronic inflammatory conditions, solid organ transplantation, or hematological malignancies. The age of onset of MCC is lower and the mortality is higher in immunosuppressed individuals than in immune-competent patients. It is plausible that HIV-1/AIDS predisposes to virus-positive MCC, but it should be noted that HIV-1/AIDS increases the risk for developing of UV-induced skin cancers such as cutaneous squamous cell carcinoma and basal cell carcinoma and therefore may also increase the risk for virus-negative MCC. Surgical management is considered standard of care for localized Merkel cell carcinoma with current recommendations advising a wide local excision of the lesion. Most international guidelines support the use of local adjuvant radiotherapy coupled with tumor staging to improve the frequency of cure. For advanced, metastatic, and recurrent MCC, checkpoint blockade inhibitors targeting PD-1 and PD-L1 have shown remarkable activity including durable long-term. MCC in patients living with HIV-1/AIDS are treated with similar modalities as HIV-1 uninfected individuals with MCC.
Collapse
Affiliation(s)
- Robert H Goldstein
- Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, USA
| | - James A DeCaprio
- Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. .,Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
| |
Collapse
|
19
|
Goldstein RH, Barkai O, Íñigo-Portugués A, Katz B, Lev S, Binshtok AM. Location and Plasticity of the Sodium Spike Initiation Zone in Nociceptive Terminals In Vivo. Neuron 2019; 102:801-812.e5. [PMID: 30926280 DOI: 10.1016/j.neuron.2019.03.005] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2018] [Revised: 01/15/2019] [Accepted: 03/01/2019] [Indexed: 11/18/2022]
Abstract
Nociceptive terminals possess the elements for detecting, transmitting, and modulating noxious signals, thus being pivotal for pain sensation. Despite this, a functional description of the transduction process by the terminals, in physiological conditions, has not been fully achieved. Here, we studied how nociceptive terminals in vivo convert noxious stimuli into propagating signals. By monitoring noxious-stimulus-induced Ca2+ dynamics from mouse corneal terminals, we found that initiation of Na+ channel (Nav)-dependent propagating signals takes place away from the terminal and that the starting point for Nav-mediated propagation depends on Nav functional availability. Acute treatment with the proinflammatory cytokines tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β) resulted in a shift of the location of Nav involvement toward the terminal, thus increasing nociceptive excitability. Moreover, a shift of Nav involvement toward the terminal occurs in corneal hyperalgesia resulting from acute photokeratitis. This dynamic change in the location of Nav-mediated propagation initiation could underlie pathological pain hypersensitivity.
Collapse
Affiliation(s)
- Robert H Goldstein
- Department of Medical Neurobiology, Institute for Medical Research Israel Canada, Faculty of Medicine, The Hebrew University, 9112001 Jerusalem, Israel; The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, 9112001 Jerusalem, Israel
| | - Omer Barkai
- Department of Medical Neurobiology, Institute for Medical Research Israel Canada, Faculty of Medicine, The Hebrew University, 9112001 Jerusalem, Israel; The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, 9112001 Jerusalem, Israel
| | - Almudena Íñigo-Portugués
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, 03550 San Juan de Alicante, Spain
| | - Ben Katz
- Department of Medical Neurobiology, Institute for Medical Research Israel Canada, Faculty of Medicine, The Hebrew University, 9112001 Jerusalem, Israel; The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, 9112001 Jerusalem, Israel
| | - Shaya Lev
- Department of Medical Neurobiology, Institute for Medical Research Israel Canada, Faculty of Medicine, The Hebrew University, 9112001 Jerusalem, Israel; The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, 9112001 Jerusalem, Israel
| | - Alexander M Binshtok
- Department of Medical Neurobiology, Institute for Medical Research Israel Canada, Faculty of Medicine, The Hebrew University, 9112001 Jerusalem, Israel; The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, 9112001 Jerusalem, Israel.
| |
Collapse
|
20
|
Affiliation(s)
- Robert H Goldstein
- From the Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital (R.H.G.), Harvard Medical School (R.H.G.), the Boston University School of Medicine, Section of General Internal Medicine and Department of Medicine, Boston Medical Center (C.G.S.), and the Fenway Institute, Fenway Health (S.R.C.) - all in Boston
| | - Carl G Streed
- From the Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital (R.H.G.), Harvard Medical School (R.H.G.), the Boston University School of Medicine, Section of General Internal Medicine and Department of Medicine, Boston Medical Center (C.G.S.), and the Fenway Institute, Fenway Health (S.R.C.) - all in Boston
| | - Sean R Cahill
- From the Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital (R.H.G.), Harvard Medical School (R.H.G.), the Boston University School of Medicine, Section of General Internal Medicine and Department of Medicine, Boston Medical Center (C.G.S.), and the Fenway Institute, Fenway Health (S.R.C.) - all in Boston
| |
Collapse
|
21
|
Moussa Y, Shuster J, Matte G, Sullivan A, Goldstein RH, Cunningham D, Ben-Shoshan M, Baldini G, Carli F, Tsoukas C. De-labeling of β-lactam allergy reduces intraoperative time and optimizes choice in antibiotic prophylaxis. Surgery 2018; 164:S0039-6060(18)30127-2. [PMID: 29751965 DOI: 10.1016/j.surg.2018.03.004] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2017] [Revised: 02/26/2018] [Accepted: 03/19/2018] [Indexed: 12/18/2022]
Abstract
BACKGROUND Suspected penicillin allergic individuals receive suboptimal non-β-lactams for intraoperative prophylaxis which may prolong operations and have negative clinical outcomes. We therefore studied if β-lactam de-labeling optimized choice of prophylactic antibiotics and improved intraoperative time efficiency. METHODS A multistep approach was used. It included a risk assessment tool by an allergist, β-lactam skin testing and oral provocation. To determine the value of de-labeling, we appraised intraoperative antibiotic choices and correlated them with time to first incision. RESULTS A total of 194 patients were evaluated preoperatively. Four patients were diagnosed β-lactam allergic on skin testing. Of the remaining 190 skin test negative patients, 146 were β-lactam challenged. Only 5% reacted and were considered β-lactam allergic. Cefazolin became the perioperative antibiotic of choice for 77% of patients requiring antibiotic prophylaxis. Only 5 confirmed β-lactam allergic patients received intraoperative vancomycin. Patients avoiding use of vancomycin saved an average of 22 minutes in operative time. Of the 44 patients not having a β-lactam challenge, 36 received antibiotics and 18 (50%) of these were prescribed intraoperative cefazolin. CONCLUSION Using this three step process, almost all of those claiming penicillin allergy were de-labeled. In most patients that were drug challenged, β-lactam antibiotics became the perioperative drug of choice. In cases where oral challenge was not used in the assessment only 50% were given a β-lactam. The reduced use of vancomycin minimized delays in initiation of incision time, thus improving operative efficiency. Ultimately, randomized controlled studies are required to objectively determine the effectiveness of this approach.
Collapse
Affiliation(s)
- Yara Moussa
- Department of Medicine, Division of Allergy and Clinical Immunology, McGill University, Montreal, Quebec, Canada; Division of Experimental Medicine, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
| | - Joseph Shuster
- Department of Medicine, Division of Allergy and Clinical Immunology, McGill University, Montreal, Quebec, Canada; Division of Experimental Medicine, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
| | - Gilbert Matte
- Department of Pharmacy, McGill University Health Center, Montreal, Quebec, Canada
| | - Andrew Sullivan
- Division of Experimental Medicine, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
| | - Robert H Goldstein
- Division of Experimental Medicine, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
| | - Dayle Cunningham
- Department of Medicine, Division of Allergy and Clinical Immunology, McGill University, Montreal, Quebec, Canada
| | - Moshe Ben-Shoshan
- Division of Experimental Medicine, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada; Department of Pediatrics, Divisions of Allergy, Immunology and Dermatology, McGill University, Montreal, Quebec, Canada
| | - Gabriele Baldini
- Department of Anesthesia, McGill University Health Center, Montreal General Hospital, Montreal, Quebec, Canada
| | - Francesco Carli
- Department of Anesthesia, McGill University Health Center, Montreal General Hospital, Montreal, Quebec, Canada
| | - Christos Tsoukas
- Department of Medicine, Division of Allergy and Clinical Immunology, McGill University, Montreal, Quebec, Canada; Division of Experimental Medicine, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
| |
Collapse
|
22
|
LaCasce AS, Flores EJ, Goldstein RH, Sohani AR. Case 25-2017. N Engl J Med 2017; 377:677-688. [PMID: 28813220 DOI: 10.1056/nejmcpc1706099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Ann S LaCasce
- From the Department of Medical Oncology, Dana-Farber Cancer Institute (A.S.L.), the Departments of Radiology (E.J.F.), Medicine (R.H.G.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (A.S.L., R.H.G.), Radiology (E.J.F.), and Pathology (A.R.S.), Harvard Medical School - all in Boston
| | - Efren J Flores
- From the Department of Medical Oncology, Dana-Farber Cancer Institute (A.S.L.), the Departments of Radiology (E.J.F.), Medicine (R.H.G.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (A.S.L., R.H.G.), Radiology (E.J.F.), and Pathology (A.R.S.), Harvard Medical School - all in Boston
| | - Robert H Goldstein
- From the Department of Medical Oncology, Dana-Farber Cancer Institute (A.S.L.), the Departments of Radiology (E.J.F.), Medicine (R.H.G.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (A.S.L., R.H.G.), Radiology (E.J.F.), and Pathology (A.R.S.), Harvard Medical School - all in Boston
| | - Aliyah R Sohani
- From the Department of Medical Oncology, Dana-Farber Cancer Institute (A.S.L.), the Departments of Radiology (E.J.F.), Medicine (R.H.G.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (A.S.L., R.H.G.), Radiology (E.J.F.), and Pathology (A.R.S.), Harvard Medical School - all in Boston
| |
Collapse
|
23
|
Goldstein RH, Katz B, Lev S, Binshtok AM. Ultrafast optical recording reveals distinct capsaicin-induced ion dynamics along single nociceptive neurite terminals in vitro. J Biomed Opt 2017; 22:76010. [PMID: 28715544 DOI: 10.1117/1.jbo.22.7.076010] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/16/2017] [Accepted: 06/26/2017] [Indexed: 06/07/2023]
Abstract
Pain signals are detected by terminals of nociceptive peripheral fibers situated among the keratinocytes and epithelial cells. Despite being key structures for pain-related stimuli detection and transmission, little is known about the functional organization of terminals. This is mainly due to their minute size, rendering them largely inaccessible by conventional experimental approaches. Here, we report the implementation of an ultrafast optical recording approach for studying cultured neurite terminals, which are readily accessible for assay manipulations. Using this approach, we were able to study capsaicin-induced calcium and sodium dynamics in the nociceptive processes, at a near-action potential time resolution. The approach was sensitive enough to detect differences in latency, time-to-peak, and amplitude of capsaicin-induced ion transients along the terminal neurites. Using this approach, we found that capsaicin evokes distinctive calcium signals along the neurite. At the terminal, the signal was insensitive to voltage-gated sodium channel blockers, and showed slower kinetics and smaller signal amplitudes, compared with signals that were measured further up the neurite. These latter signals were mainly abolished by sodium channel blockers. We propose this ultrafast optical recording approach as a model for studying peripheral terminal signaling, forming a basis for studying pain mechanisms in normal and pathological states.
Collapse
Affiliation(s)
- Robert H Goldstein
- The Hebrew University, Institute for Medical Research Israel Canada, Faculty of Medicine, Department of Medical Neurobiology, Jerusalem, IsraelbThe Hebrew University, The Edmond and Lily Safra Center for Brain Sciences, Jerusalem, Israel
| | - Ben Katz
- The Hebrew University, Institute for Medical Research Israel Canada, Faculty of Medicine, Department of Medical Neurobiology, Jerusalem, IsraelbThe Hebrew University, The Edmond and Lily Safra Center for Brain Sciences, Jerusalem, Israel
| | - Shaya Lev
- The Hebrew University, Institute for Medical Research Israel Canada, Faculty of Medicine, Department of Medical Neurobiology, Jerusalem, IsraelbThe Hebrew University, The Edmond and Lily Safra Center for Brain Sciences, Jerusalem, Israel
| | - Alexander M Binshtok
- The Hebrew University, Institute for Medical Research Israel Canada, Faculty of Medicine, Department of Medical Neurobiology, Jerusalem, IsraelbThe Hebrew University, The Edmond and Lily Safra Center for Brain Sciences, Jerusalem, Israel
| |
Collapse
|
24
|
Barkai O, Goldstein RH, Caspi Y, Katz B, Lev S, Binshtok AM. The Role of Kv7/M Potassium Channels in Controlling Ectopic Firing in Nociceptors. Front Mol Neurosci 2017; 10:181. [PMID: 28659757 PMCID: PMC5468463 DOI: 10.3389/fnmol.2017.00181] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2017] [Accepted: 05/24/2017] [Indexed: 11/13/2022] Open
Abstract
Peripheral nociceptive neurons encode and convey injury-inducing stimuli toward the central nervous system. In normal conditions, tight control of nociceptive resting potential prevents their spontaneous activation. However, in many pathological conditions the control of membrane potential is disrupted, leading to ectopic, stimulus-unrelated firing of nociceptive neurons, which is correlated to spontaneous pain. We have investigated the role of KV7/M channels in stabilizing membrane potential and impeding spontaneous firing of nociceptive neurons. These channels generate low voltage-activating, noninactivating M-type K+ currents (M-current, IM ), which control neuronal excitability. Using perforated-patch recordings from cultured, rat nociceptor-like dorsal root ganglion neurons, we show that inhibition of M-current leads to depolarization of nociceptive neurons and generation of repetitive firing. To assess to what extent the M-current, acting at the nociceptive terminals, is able to stabilize terminals' membrane potential, thus preventing their ectopic activation, in normal and pathological conditions, we built a multi-compartment computational model of a pseudo-unipolar unmyelinated nociceptive neuron with a realistic terminal tree. The modeled terminal tree was based on the in vivo structure of nociceptive peripheral terminal, which we assessed by in vivo multiphoton imaging of GFP-expressing nociceptive neuronal terminals innervating mice hind paw. By modifying the conductance of the KV7/M channels at the modeled terminal tree (terminal gKV7/M) we have found that 40% of the terminal gKV7/M conductance is sufficient to prevent spontaneous firing, while ~75% of terminal gKV7/M is sufficient to inhibit stimulus induced activation of nociceptive neurons. Moreover, we showed that terminal M-current reduces susceptibility of nociceptive neurons to a small fluctuations of membrane potentials. Furthermore, we simulated how the interaction between terminal persistent sodium current and M-current affects the excitability of the neurons. We demonstrated that terminal M-current in nociceptive neurons impeded spontaneous firing even when terminal Na(V)1.9 channels conductance was substantially increased. On the other hand, when terminal gKV7/M was decreased, nociceptive neurons fire spontaneously after slight increase in terminal Na(V)1.9 conductance. Our results emphasize the pivotal role of M-current in stabilizing membrane potential and hereby in controlling nociceptive spontaneous firing, in normal and pathological conditions.
Collapse
Affiliation(s)
- Omer Barkai
- Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Hadassah School of Medicine, The Hebrew University-Hadassah School of MedicineJerusalem, Israel.,The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of JerusalemJerusalem, Israel
| | - Robert H Goldstein
- Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Hadassah School of Medicine, The Hebrew University-Hadassah School of MedicineJerusalem, Israel.,The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of JerusalemJerusalem, Israel
| | - Yaki Caspi
- Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Hadassah School of Medicine, The Hebrew University-Hadassah School of MedicineJerusalem, Israel.,The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of JerusalemJerusalem, Israel
| | - Ben Katz
- Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Hadassah School of Medicine, The Hebrew University-Hadassah School of MedicineJerusalem, Israel.,The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of JerusalemJerusalem, Israel
| | - Shaya Lev
- Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Hadassah School of Medicine, The Hebrew University-Hadassah School of MedicineJerusalem, Israel.,The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of JerusalemJerusalem, Israel
| | - Alexander M Binshtok
- Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Hadassah School of Medicine, The Hebrew University-Hadassah School of MedicineJerusalem, Israel.,The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of JerusalemJerusalem, Israel
| |
Collapse
|
25
|
Affiliation(s)
- Meghan E Sise
- From the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Massachusetts General Hospital, and the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Harvard Medical School - both in Boston
| | - Grace C Lo
- From the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Massachusetts General Hospital, and the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Harvard Medical School - both in Boston
| | - Robert H Goldstein
- From the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Massachusetts General Hospital, and the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Harvard Medical School - both in Boston
| | - Andrew S Allegretti
- From the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Massachusetts General Hospital, and the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Harvard Medical School - both in Boston
| | - Ricard Masia
- From the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Massachusetts General Hospital, and the Departments of Medicine (M.E.S., R.H.G., A.S.A.), Radiology (G.C.L.), and Pathology (R.M.), Harvard Medical School - both in Boston
| |
Collapse
|
26
|
Sacks CA, Goldstein RH, Walensky RP. The Blood Supply and Men Who Have Sex with Men. N Engl J Med 2017; 376:1486. [PMID: 28402775 DOI: 10.1056/nejmc1701828] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
27
|
Affiliation(s)
- Chana A Sacks
- From the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital (C.A.S.), the Divisions of General Internal Medicine (C.A.S., R.P.W.) and Infectious Disease (R.H.G., R.P.W.) and the Medical Practice Evaluation Center (R.P.W.), Massachusetts General Hospital, and the Harvard University Center for AIDS Research, Harvard Medical School (R.P.W.) - all in Boston
| | - Robert H Goldstein
- From the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital (C.A.S.), the Divisions of General Internal Medicine (C.A.S., R.P.W.) and Infectious Disease (R.H.G., R.P.W.) and the Medical Practice Evaluation Center (R.P.W.), Massachusetts General Hospital, and the Harvard University Center for AIDS Research, Harvard Medical School (R.P.W.) - all in Boston
| | - Rochelle P Walensky
- From the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital (C.A.S.), the Divisions of General Internal Medicine (C.A.S., R.P.W.) and Infectious Disease (R.H.G., R.P.W.) and the Medical Practice Evaluation Center (R.P.W.), Massachusetts General Hospital, and the Harvard University Center for AIDS Research, Harvard Medical School (R.P.W.) - all in Boston
| |
Collapse
|
28
|
Hiemstra EJ, Goldstein RH. Repeated injection of hydrothermal fluids into downdip carbonates: a diagenetic and stratigraphic mechanism for localization of reservoir porosity, Indian Basin Field, New Mexico, USA. ACTA ACUST UNITED AC 2014. [DOI: 10.1144/sp406.1] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
AbstractA detailed study of the Pennsylvanian Indian Basin Field of New Mexico, USA is used to develop a conceptual model that predicts reservoir porosity in clean down-depositional-dip marine carbonate, where repeated fracturing allows for hydrothermal fluid flow. Strata updip probably experienced repeated events of subaerial exposure, resulting in mineralogical stabilization and extensive calcite cementation that prevented extensive hydrothermal alteration. Clean, carbonate sediment deposited downdip was more prone to alteration by hydrothermal fluids. In the reservoir, cement stratigraphy shows regionally persistent zones closely associated with fracturing. Fluid inclusion data show high temperatures and repeated rises and falls, indicating tectonic valving in a hydrothermal system. Salinity data support this and indicate a late event of meteoric influx. Sr- and O-isotope data indicate higher temperature and less rock–water interaction in fault damage zones, evidence for intensified fluid flow in such areas. Formation of vugs and molds was associated with the hydrothermal fluid flow, which was driven by convection, probably initiated during 40–30 Ma intrusive activity and continuing after the onset of Basin and Range uplift and unroofing.
Collapse
Affiliation(s)
- Erik J. Hiemstra
- Department of Geology, KICC, University of Kansas, 1475 Jayhawk Boulevard, Lawrence, KS 66045, USA
- Present address: Marathon Oil Corporation, Mid-Continent Asset Team, Oklahoma City, Oklahoma, USA
| | - Robert H. Goldstein
- Department of Geology, KICC, University of Kansas, 1475 Jayhawk Boulevard, Lawrence, KS 66045, USA
| |
Collapse
|
29
|
Goldstein RH. A case of a false confession after an inadvertent hypnotic induction. Am J Clin Hypn 2012; 55:56-67. [PMID: 22913227 DOI: 10.1080/00029157.2012.684161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
This article presents the case of a highly hypnotizable 28-year-old man who gave a false confession under police interrogation following an unintended hypnotic induction, but who was exonerated years later on the basis of DNA evidence. The author proposes that assessment of possible high hypnotizability be conducted in instances of otherwise unsubstantiated confessions.
Collapse
|
30
|
Abstract
The present study demonstrates pDNA complexes of recombinant silk proteins containing poly(L-lysine) and tumor-homing peptides (THPs), which are globular and approximately 150-250 nm in diameter, show significant enhancement of target specificity to tumor cells by additions of F3 and CGKRK THPs. We report herein the preparation and study of novel nanoscale silk-based ionic complexes containing pDNA able to home specifically to tumor cells. Particular focus was on how the THP, F3 (KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK), and CGKRK, enhanced transfection specificity to tumor cells. Genetically engineered silk proteins containing both poly(L-lysine) domains to interact with pDNA and the THP to bind to specific tumor cells for target-specific pDNA delivery were prepared using Escherichia coli, followed by in vitro and in vivo transfection experiments into MDA-MB-435 melanoma cells and highly metastatic human breast tumor MDA-MB-231 cells. Non-tumorigenic MCF-10A breast epithelial cells were used as a control cell line for in vitro tumor-specific delivery studies. These results demonstrate that combination of the bioengineered silk delivery systems and THP can serve as a versatile and useful new platform for nonviral gene delivery.
Collapse
Affiliation(s)
- Keiji Numata
- Department of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, Massachusetts 02155, United States
| | | | | | | | | |
Collapse
|
31
|
Goldstein RH, Reagan MR, Anderson K, Kaplan DL, Rosenblatt M. Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 2011; 70:10044-50. [PMID: 21159629 DOI: 10.1158/0008-5472.can-10-1254] [Citation(s) in RCA: 150] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
American women have a nearly 25% lifetime risk of developing breast cancer, with 20% to 40% of these patients developing life-threatening metastases. More than 70% of patients presenting with metastases have skeletal involvement, which signals progression to an incurable stage. Tumor-stroma cell interactions are only superficially understood, specifically regarding the ability of stromal cells to affect metastasis. In vivo models show that exogenously supplied human bone marrow-derived stem cells (hBMSC) migrate to breast cancer tumors, but no reports have shown endogenous hBMSC migration from the bone to primary tumors. Here, we present a model of in vivo hBMSC migration from a physiologic human bone environment to human breast tumors. Furthermore, hBMSCs alter tumor growth and bone metastasis frequency. These may home to certain breast tumors based on tumor-derived TGF-β1. Moreover, at the primary tumor level, interleukin 17B (IL-17B)/IL-17BR signaling may mediate interactions between hBMSCs and breast cancer cells.
Collapse
Affiliation(s)
- Robert H Goldstein
- Program in Genetics, Sackler School of Biomedical Sciences, Tufts University, Boston, Massachusetts, USA
| | | | | | | | | |
Collapse
|
32
|
Affiliation(s)
- Robert H Goldstein
- Program in Genetics, Tufts University Sackler School of Biomedical Sciences, Boston, MA, USA
| | | | | |
Collapse
|
33
|
Kenward PA, Goldstein RH, González LA, Roberts JA. Precipitation of low-temperature dolomite from an anaerobic microbial consortium: the role of methanogenic Archaea. Geobiology 2009; 7:556-565. [PMID: 19663931 DOI: 10.1111/j.1472-4669.2009.00210.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Here we report precipitation of dolomite at low temperature (30 degrees C) mediated by a mixed anaerobic microbial consortium composed of dissimilatory iron-reducing bacteria (DIRB), fermenters, and methanogens. Initial solution geochemistry is controlled by DIRB, but after 90 days shifts to a system dominated by methanogens. In live experiments conditions are initially saturated with respect to dolomite (Omega(dol) = 19.40) and increase by two orders of magnitude (Omega(dol) = 2 330.77) only after the onset of methanogenesis, as judged by the increasing [CH(4)] and the detection of methanogenic micro-organisms. We identify ordered dolomite in live microcosms after 90 days via powder X-ray diffraction, while sterile controls precipitate only calcite. Scanning electron microscopy and transmitted electron microscopy demonstrate that the precipitated dolomite is closely associated with cell walls and putative extra-cellular polysaccharides. Headspace gas measurements and denaturing gradient gel electrophoresis confirm the presence of both autotrophic and acetoclastic methanogens and exclude the presence of DIRB and sulfate-reducing bacteria after dolomite begins forming. Furthermore, the absence of dolomite in the controls and prior to methanogenesis confirm that methanogenic Archaea are necessary for the low-temperature precipitation of dolomite under the experimental conditions tested.
Collapse
MESH Headings
- Anaerobiosis
- Archaea/genetics
- Archaea/metabolism
- Archaea/ultrastructure
- Bacteria/genetics
- Bacteria/metabolism
- Calcium Carbonate/metabolism
- Cold Temperature
- DNA Fingerprinting
- DNA, Archaeal/genetics
- DNA, Bacterial/genetics
- DNA, Ribosomal/genetics
- Electrophoresis, Polyacrylamide Gel
- Iron/metabolism
- Magnesium/metabolism
- Methane/metabolism
- Microscopy, Electron, Scanning
- Microscopy, Electron, Transmission
- Minnesota
- Nucleic Acid Denaturation
- Oxidation-Reduction
- RNA, Ribosomal, 16S/genetics
- Soil Microbiology
- X-Ray Diffraction
Collapse
Affiliation(s)
- P A Kenward
- Department of Geology, University of Kansas, Lawrence, KS, USA
| | | | | | | |
Collapse
|
34
|
Liu S, Goldstein RH, Scepansky EM, Rosenblatt M. Abstract A63: Inhibition of ROCK signaling prevents breast cancer metastasis to human bone. Cancer Res 2009. [DOI: 10.1158/0008-5472.fbcr09-a63] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
ROCK signaling plays a fundamental role in regulating cell morphology, adhesion and motility. Aberrant expression of ROCK is related to tumor metastases and correlates with poor clinical outcome. However, the molecular mechanisms responsible for ROCK-mediated effects and the potential utility of ROCK inhibition as a therapeutic target have not been fully investigated. Here, we show that ROCK expression is increased in metastatic human breast cancer (BrCa) cell lines and clinical mammary tumors compared to non-metastatic cell lines and tumors. Inhibition of ROCK activity, either by a specific ROCK inhibitor (Y27632) or ROCK-targeted siRNAs, reduces BrCa cell migration and proliferation in vitro. We evaluated the effect of ROCK inhibition on metastasis to bone in vivo using a novel “human BrCa metastasis to human bone” mouse model. Metastases to human bone cores (hBCs) were inhibited in Y27632-treated mice (5 out of 14, 36%) compared to control mice (8 out of 12, 67%), based on luminescent imaging. The overall frequency of metastasis to mouse skeleton in Y27632-treated mice was reduced by 36% compared to controls. Moreover, the mass of metastatic tumors in the mouse skeleton was diminished by 77% (P<0.05) in Y27632-treated mice. ROCK1 siRNAs also decrease the frequency of BrCa metastasis to hBCs and mouse skeleton, but to a lesser extent than Y27632. We demonstrate that ROCK's effects on tumor cell invasion/motility and growth may derive from regulating the actin-myosin cytoskeleton, modulating the c-Myc pathway by increasing the stabilization of c-Myc protein via phosphorylation, and targeting c-miRNAs. Coupled to increased c-Myc, expression of the c-Myc-regulated miR-17-92 cluster is shown here to be elevated in metastatic BrCa cells compared to non-metastatic cells, and diminished upon Y27632 treatment. Furthermore, blockade of miR-17 is shown to decrease BrCa cell invasion/migration in vitro and metastasis in vivo. Collectively, these findings suggest that augmented ROCK signaling contributes to BrCa metastasis in at least 3 ways, by 1) regulating the actin cytoskeleton and actin-myosin-dependent contractility; 2) targeting mRNAs controlled by the transcription factor c-Myc to potentiate cell growth and viability; and 3) modulating the expression of certain miRNAs, such as the c-Myc-regulated oncogenic miR-17-92 cluster. Inhibition of ROCK-mediated signaling appears to be a promising and potentially specific approach to suppress the occurrence of bone metastases in BrCa.
Citation Information: Cancer Res 2009;69(23 Suppl):A63.
Collapse
Affiliation(s)
- Sijin Liu
- Tufts University School of Medicine, Boston, MA
| | | | | | | |
Collapse
|
35
|
Abstract
Rho-associated kinase (ROCK) signaling plays a fundamental role in regulating cell morphology, adhesion, and motility. Aberrant expression of ROCK is related to tumor metastases and poor clinical outcome. Here, we show that ROCK expression is increased in metastatic human mammary tumors and breast cancer cell lines compared with nonmetastatic tumors and cell lines. Overexpression of ROCK confers a metastatic phenotype on the nonmetastatic MCF-7 cell line. Inhibition of ROCK activity, by either a specific ROCK inhibitor (Y27632) or ROCK-targeted small interfering RNAs, reduces cell migration and proliferation in vitro and metastasis to bone in vivo using a novel "human breast cancer metastasis to human bone" mouse model. Expression of the c-Myc-regulated miR-17-92 cluster is shown to be elevated in metastatic breast cancer cells compared with nonmetastatic cells and diminished by Y27632 treatment. Furthermore, blockade of miR-17 is shown to decrease breast cancer cell invasion/migration in vitro and metastasis in vivo. Together, these findings suggest that augmented ROCK signaling contributes to breast cancer metastasis. The effects of ROCK on tumor cell invasion/motility and growth may derive from regulating cytoskeletal actin-myosin contraction and modulating the c-Myc pathway, including c-Myc-dependent microRNAs. Inhibition of ROCK or the pathway it stimulates, therefore, may represent a novel approach for treatment of breast cancer metastases.
Collapse
Affiliation(s)
- Sijin Liu
- Department of Physiology, Tufts University School of Medicine, Boston, Massachusetts 02111-1800, USA
| | | | | | | |
Collapse
|
36
|
|
37
|
Abstract
Cells of the bacterium Pseudomonas aeruginosa, which were genetically modified to produce green fluorescent protein, were entrapped in fluid inclusions in laboratory-grown halite. The bacteria were used to inoculate NaCl-saturated aqueous solutions, which were allowed to evaporate and precipitate halite. The number, size, and distribution of fluid inclusions were highly variable, but did not appear to be affected by the presence of the bacteria. Many of the inclusions in crystals from inoculated solutions contained cells in populations ranging from two to 20. Microbial attachment to crystal surfaces was neither evident nor necessary for entrapment. Cells occurred exclusively within fluid inclusions and were not present in the crystal matrix. In both the inclusions and the hypersaline solution, the cells fluoresced and twitched, which indicates that the bacteria might have remained viable after entrapment. The fluorescence continued up to 13 months after entrapment, which indicates that little degradation of the bacteria occurred over that time interval. The entrapment, fluorescence, and preservation of cells were independent of the volume of hypersaline solution used or whether the solutions were completely evaporated prior to crystal extraction. The results of this study have a wide range of implications for the long-term survival of microorganisms in fluid inclusions and their detection through petrography. The results also demonstrate the preservation potential for microbes in hypersaline fluid inclusions, which could allow cells to survive harsh conditions of space, the deep geologic past, or burial in sedimentary basins.
Collapse
Affiliation(s)
- James C Adamski
- Department of Geology, University of Kansas, Lawrence, Kansas, USA.
| | | | | |
Collapse
|
38
|
Abstract
We report on a case of a female patient who was successfully treated with hypnosis for warts on 2 occasions separated by an interval of 7 years. Of note is the fact that she had low expectations regarding the benefit to be derived from hypnosis and did not at first appear to be highly hypnotizable.
Collapse
|
39
|
Cornette JL, Lieberman BS, Goldstein RH. Documenting a significant relationship between macroevolutionary origination rates and Phanerozoic pCO2 levels. Proc Natl Acad Sci U S A 2002; 99:7832-5. [PMID: 12048255 PMCID: PMC122979 DOI: 10.1073/pnas.122225499] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
We show that the rates of diversification of the marine fauna and the levels of atmospheric CO(2) have been closely correlated for the past 545 million years. These results, using two of the fundamental databases of the Earth's biota and the Earth's atmospheric composition, respectively, are highly statistically significant (P < 0.001). The strength of the correlation suggests that one or more environmental variables controlling CO(2) levels have had a profound impact on evolution throughout the history of metazoan life. Comparing our work with highly significant correlations described by D. H. Rothman [Rothman, D. H. (2001) Proc. Natl. Acad. Sci. USA 98, 4305-4310] between total biological diversity and a measure of stable carbon isotope fractionation, we find that the rates of diversification rather than total diversification correlate with environmental variables, and that the rate of diversification follows the record of CO(2) projected by R. A. Berner and Z. Kothavala [Berner, R. A. & Kothavala, Z. (2001) Am. J. Sci. 301, 182-204] more closely than that predicted by Rothman.
Collapse
Affiliation(s)
- James L Cornette
- Department of Geology, University of Kansas, Lawrence, KS 66045, USA.
| | | | | |
Collapse
|
40
|
Abstract
All-trans-retinoic acid (ATRA) has anti-fibrotic and antiinflammatory properties, and may be useful as a therapeutic agent in lung fibrosis. To test this hypothesis we investigated the effect of ATRA on bleomycin-induced lung fibrosis in Sprague-Dawley rats. Treatment groups included: (1) a single intratracheal (i.t.) instillation of bleomycin and daily intraperitoneal (i.p.) injection of 0.5 mg/kg per day ATRA; (2) i.t. bleomycin and i.p. ATRA, 2 mg/kg per day, (3) i.t. bleomycin and i.p. diluent (cottonseed oil); (4) i.t. saline and i.p. ATRA, 0.5 mg/kg per day, (5) i.t. saline and i.p. ATRA, 2 mg/kg per day; and (6) i.t. saline and i.p. diluent. Animals were studied 14 days after i.t. instillation. Lung injury was evaluated by total and differential cell count in bronchoalveolar lavage fluid, by a semi-quantitative morphological index of lung injury, and by biochemical analysis of lung hydroxyproline content. Overt signs of lung injury were apparent in bleomycin-treated rats by all measures. These changes were not affected by treatment with ATRA at either dose. This study does not support the use of ATRA to prevent or ameliorate lung fibrosis.
Collapse
Affiliation(s)
- M J Segel
- Lung Cellular & Molecular Biology Laboratory, Institute of Pulmonology, Hadassah University Hospital, Hebrew University, Hadassah Medical School, Jerusalem, Israel
| | | | | | | | | | | | | |
Collapse
|
41
|
Affiliation(s)
- R H Goldstein
- Department of Geology, University of Kansas, Lawrence, KS 66045, USA.
| |
Collapse
|
42
|
Abstract
We investigated the effect of the dietary flavonoid apigenin on myofibroblast function. We report that in myofibroblasts treated with apigenin, proliferation and basal levels of alpha1(I) collagen and alpha-smooth muscle actin mRNAs were markedly reduced. Apigenin also attenuated the transforming growth factor-beta-stimulated increases of alpha1(I) collagen and alpha-smooth muscle actin mRNAs. Characterization of the apigenin effects indicates that apigenin reduces both the stability of the alpha1(I) collagen mRNA and the rate of transcription of the alpha1(I) collagen gene through a cycloheximide-sensitive pathway. Western blot analyses indicate that Akt activity is reduced in apigenin-treated myofibroblasts.
Collapse
Affiliation(s)
- D A Ricupero
- Pulmonary Center, Boston University School of Medicine and the Boston VA Medical Center, 02118, Boston, MA 02118, USA.
| | | | | | | | | |
Collapse
|
43
|
Berkman N, Kremer S, Or R, Lossos IS, Christensen TG, Goldstein RH, Breuer R. Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury. Respiration 2001; 68:169-77. [PMID: 11287832 DOI: 10.1159/000050488] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Bleomycin (Bleo)-induced lung injury in mice serves as an animal model of pulmonary fibrosis. The pathogenesis of pulmonary fibrosis remains unclear, but it comprises both inflammatory and fibrotic components. The cytokine interferon (IFN)-alpha is produced by macrophages and may modulate both fibrogenesis and the determination of T lymphocyte phenotype in pulmonary fibrosis. OBJECTIVE To investigate the effect of two preparations of recombinant IFN-alpha (IFN-alphaA/D and IFN-alpha2a) on Bleo-induced lung injury in C57BL/6 mice. METHODS Mice were treated by a single intratracheal (IT) instillation of 0.06 mg of Bleo in 0.1 ml of saline or saline alone. One of two different IFN-alpha preparations, IFN-alphaA/D or IFN-alpha2a in saline, or saline alone were administered by daily intraperitoneal injections starting 1 day prior to IT instillation. The treatment groups were as follows: IT Bleo and intraperitoneal saline; IT Bleo and intraperitoneal IFN-alpha2a; IT Bleo and intraperitoneal IFN-alphaA/D; IT saline and intraperitoneal IFN-alphaA/D or IFN-alpha2a; IT saline and intraperitoneal saline. The animals were sacrificed 14 days after IT instillation. Lung injury was evaluated by total and differential cell count in bronchoalveolar lavage (BAL) fluid, by a semiquantitative morphological index of lung injury and a quantitative image analysis of cellularity and fibrosis fraction and by biochemical analysis of lung hydroxyproline content. RESULTS In Bleo-treated mice, IFN-alpha2a treatment caused a significant rise in BAL lymphocytes and in cellularity and fibrosis fractions in lung tissue. In contrast, IFN-alphaA/D treatment had no effect on Bleo-induced lung injury. CONCLUSION IFN-alpha may enhance Bleo-induced lung injury but this effect varies with different IFN preparations.
Collapse
Affiliation(s)
- N Berkman
- Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonology, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem, Israel.
| | | | | | | | | | | | | |
Collapse
|
44
|
Ricupero DA, Poliks CF, Rishikof DC, Cuttle KA, Kuang PP, Goldstein RH. Phosphatidylinositol 3-kinase-dependent stabilization of alpha1(I) collagen mRNA in human lung fibroblasts. Am J Physiol Cell Physiol 2001; 281:C99-C105. [PMID: 11401831 DOI: 10.1152/ajpcell.2001.281.1.c99] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We investigated the role of phosphatidylinositol 3-kinase (PI3K) in the expression of alpha1(I) collagen mRNA. We report that the basal level of alpha1(I) collagen mRNA was reduced when PI3K activity was inhibited by either LY-294002 or wortmannin. These PI3K inhibitors also blocked increases of alpha1(I) collagen mRNA levels after the addition of transforming growth factor-beta. The effect of PI3K inhibition was abolished by the removal of the inhibitor or by the addition of cycloheximide. Inhibition of PI3K activity decreased the stability of the alpha1(I) collagen mRNA with no change in the rate of transcription of the alpha1(I) collagen gene as assessed by Northern blotting with actinomycin D-treated fibroblasts and nuclear run-on assays. Expression of a truncated alpha1(I) collagen minigene driven by a cytomegalovirus promoter in murine fibroblasts was decreased by LY-294002 treatment. These data indicate that PI3K activation results in increased stabilization of alpha1(I) collagen mRNA. In vivo, the PI3K activity in fibroblasts may regulate basal levels of alpha1(I) collagen mRNA expression.
Collapse
Affiliation(s)
- D A Ricupero
- Pulmonary Center and Department of Biochemistry at Boston University School of Medicine and Boston Veterans Affairs Medical Center, Boston, Massachusetts 02118, USA.
| | | | | | | | | | | |
Collapse
|
45
|
Abstract
Since transforming growth factor beta (TGF-beta) is presumed to play a role in lung fibrosis, we evaluated the effect of suramin (Sur), a substance with an anti-TGF-beta effect, in vivo on bleomycin (Bleo)-induced pulmonary injury in mice and in vitro on human lung fibroblasts. Four groups of C57BL/6 mice each received one of four treatments: (1) intratracheal (i.t.) instillation of Bleo and intraperitoneal (i.p.) injections of Sur, every other day, starting one day before i.t. instillation of Bleo (Bleo-Sur); (2) i.t. Bleo and i.p. injections of saline (Bleo-Sal); (3) i.t. saline and i.p. Sur (Sal-Sur); and (4) i.t. and i.p. saline (Sal-Sal). Animals were sacrificed 14 days after i.t. treatment. Lung injury was evaluated by analysis of bronchoalveolar lavage (BAL) fluid, histologically by the semiquantitative morphological index, and biochemically by analysis of lung hydroxyproline content. In vitro, Sur did not affect TGF-beta induced increase of alpha1 (I) collagen mRNA in human lung fibroblasts. In vivo treatment of mice with Sur did not affect Bleo-induced lung injury. These results indicate that despite its potential anti TGF-beta and lymphocytotoxic effects, Sur is not a therapeutic candidate drug for rescue of lung fibrosis.
Collapse
Affiliation(s)
- I S Lossos
- Lung Cellular & Molecular Biology Laboratory-Institute of Pulmonology, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem, Israel
| | | | | | | | | |
Collapse
|
46
|
Abstract
Hypoxia and amino acid deprivation downregulate expression of extracellular matrix genes in lung fibroblasts. We examined the effect of hypoxia on amino acid uptake and protein formation in human lung fibroblasts. Low O(2) tension (0% O(2)) suppressed incorporation of [(3)H]proline into type I collagen without affecting [(35)S]methionine labeling of other proteins. Initial decreases in intracellular [(3)H]proline incorporation occurred after 2 h of exposure to 0% O(2), with maximal suppression of intracellular [(3)H]proline levels at 6 h of treatment. Hypoxia significantly inhibited the uptake of radiolabeled proline, 2-aminoisobutyric acid (AIB), and 2-(methylamino)isobutyric acid (methyl-AIB) while inducing minor decreases in leucine transport. Neither cycloheximide nor indomethacin abrogated hypoxia-related suppression of methyl-AIB uptake. Efflux studies demonstrated that hypoxia inhibited methyl-AIB transport in a bidirectional fashion. The downregulation of amino acid transport was not due to a toxic effect; function recovered on return to standard O(2) conditions. Kinetic analysis of AIB transport revealed a 10-fold increase in K(m) accompanied by a small increase in maximal transport velocity among cells exposed to 0% O(2). These data indicate that low O(2) tension regulates the system A transporter by decreasing transporter substrate affinity.
Collapse
Affiliation(s)
- J L Berk
- The Pulmonary Center, Boston University School of Medicine, and Boston Veterans Affairs Medical Center, Boston, Massachusetts 02118, USA.
| | | | | |
Collapse
|
47
|
Ricupero DA, Romero JR, Rishikof DC, Goldstein RH. Des-Arg(10)-kallidin engagement of the B1 receptor stimulates type I collagen synthesis via stabilization of connective tissue growth factor mRNA. J Biol Chem 2000; 275:12475-80. [PMID: 10777533 DOI: 10.1074/jbc.275.17.12475] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Expression of the kinin B1 receptor is up-regulated in chronic inflammatory and fibrotic disorders; however, little is known about its role in fibrogenesis. We examined human embryonic lung fibroblasts that constitutively express the B1 receptor and report that engagement of the B1 receptor by des-Arg(10)-kallidin stabilized connective tissue growth factor (CTGF) mRNA, stimulated an increase in alpha1(I) collagen mRNA, and stimulated type I collagen production. These events were not observed in B2 receptor-activated fibroblasts. In addition, B1 receptor activation by des-Arg(10)-kallidin induced a rise in cytosolic Ca(2+) that is consistent with B1 receptor pharmacology. Our results show that the des-Arg(10)-kallidin-stimulated increase in alpha1(I) collagen mRNA was time- and dose-dependent, with a peak response observed at 20 h with 100 nM des-Arg(10)-kallidin. The increase in CTGF mRNA was also time- and dose-dependent, with a peak response observed at 4 h with 100 nM des-Arg(10)-kallidin. The increase in CTGF mRNA was blocked by the B1 receptor antagonist des-Arg(10),Leu(9)-kallidin. Inhibition of protein synthesis by cycloheximide did not block the des-Arg(10)-kallidin-induced increase in CTGF mRNA. These results suggest that engagement of the kinin B1 receptor contributes to fibrogenesis through increased expression of CTGF.
Collapse
Affiliation(s)
- D A Ricupero
- Pulmonary Center, Departments of Medicine and Biochemistry, Boston University School of Medicine and the Boston Veterans Affairs Medical Center, Boston, Massachusetts 02118-2394, USA.
| | | | | | | |
Collapse
|
48
|
Ricupero DA, Rishikof DC, Kuang PP, Poliks CF, Goldstein RH. Regulation of connective tissue growth factor expression by prostaglandin E(2). Am J Physiol 1999; 277:L1165-71. [PMID: 10600887 DOI: 10.1152/ajplung.1999.277.6.l1165] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Transforming growth factor-beta (TGF-beta) stimulates alpha(1)(I) collagen mRNA synthesis in human lung fibroblasts through a mechanism that is partially sensitive to cycloheximide and that may involve synthesis of connective tissue growth factor (CTGF). Northern blot analyses indicate that TGF-beta stimulates time- and dose-dependent increases in CTGF mRNA. In TGF-beta-stimulated fibroblasts, maximal levels of CTGF mRNA (3.7-fold above baseline) occur at 6 h. The TGF-beta-stimulated increase in CTGF mRNA was not blocked by cycloheximide. Nuclear run-on analysis indicates that TGF-beta increases the CTGF transcription rate. The TGF-beta-stimulated increases in CTGF transcription and steady-state levels of CTGF mRNA are attenuated in prostaglandin E(2) (PGE(2))-treated fibroblasts. PGE(2) fails to attenuate luciferase activity induced by TGF-beta in fibroblasts transfected with the TGF-beta-responsive luciferase reporter construct p3TP-LUX. In amino acid-deprived fibroblasts, PGE(2) and insulin regulate alpha(1)(I) collagen mRNA levels without affecting CTGF mRNA levels. The data suggest that the regulation of alpha(1)(I) collagen mRNA levels by TGF-beta and PGE(2) may function through both CTGF-dependent and CTGF-independent mechanisms.
Collapse
Affiliation(s)
- D A Ricupero
- Pulmonary Center and Department of Biochemistry, Boston University School of Medicine, Boston 02118-2394, USA.
| | | | | | | | | |
Collapse
|
49
|
Kremer S, Breuer R, Lossos IS, Berkman N, Christensen TG, Connor MW, Goldstein RH, Or R. Effect of immunomodulators on bleomycin-induced lung injury. Respiration 1999; 66:455-62. [PMID: 10516543 DOI: 10.1159/000029410] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND The role of lymphocytes and their subpopulations in lung fibrosis is as yet unclear. OBJECTIVE To define the role of immunomodulation in bleomycin-induced inflammatory fibrotic lung injury, by testing the effect of two known Th1 inhibitors: linomide and pentoxifylline. METHODS C57BL/6 mice were treated by a single intratracheal instillation of 0.06 mg bleomycin in 0.01 ml saline or saline alone. Treatment groups included: (1) intratracheal bleomycin and daily treatment with linomide or pentoxifylline; (2) intratracheal bleomycin and daily water; (3) intratracheal saline and daily linomide or pentoxifylline; (4) intratracheal saline and daily water. Linomide and pentoxifylline were available per os in the drinking water from 1 day prior to intratracheal instillation. Animals were studied 14 days after intratracheal instillation. Lung injury was evaluated by total and differential cell count in bronchoalveolar lavage fluid, by a semiquantitative morphological index of lung injury and a quantitative image analysis of cellularity, fibrosis fraction and alveolar wall area fraction, and by biochemical analysis of lung hydroxyproline content. RESULTS Linomide or pentoxifylline did not cause any lung injury in saline-treated control mice. Overt signs of lung injury were apparent in bleomycin-treated mice. These changes were not affected by daily treatment with linomide or pentoxifylline, which were given in the highest tolerable dose. CONCLUSION This study does not support the use of linomide or pentoxifylline to prevent or ameliorate lung fibrosis and may suggest that drug-induced differentiation of T lymphocytes into Th1/th2 subpopulations does not affect the evolution of bleomycin-induced lung injury.
Collapse
Affiliation(s)
- S Kremer
- Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonology, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem, Israel
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Rishikof DC, Ricupero DA, Poliks CF, Goldstein RH. Amino acid availability regulates type I procollagen accumulation in human lung fibroblasts. J Cell Biochem 1999; 75:130-7. [PMID: 10462711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
Fibrotic lung diseases are characterized by excessive deposition of type I collagen. Amino acid availability regulates type I collagen mRNA levels in quiescent human lung fibroblasts. In these studies, the effect of amino acid availability on type I collagen protein accumulation in quiescent human lung fibroblasts was examined. Following amino acid deprivation, alpha1(I) procollagen protein levels were not detected by Western blot analysis in either the intracellular or the extracellular compartments. Fibronectin levels and total protein levels were not affected. Amino acid deprivation resulted in a more pronounced decrease in alpha1(I) procollagen protein levels than in alpha1(I) procollagen mRNA levels, suggesting that post-transcriptional events were responsible for the further decrease inalpha1(I) procollagen protein levels. The addition of transforming growth factor-beta to amino acid deprived fibroblasts increased alpha1(I) procollagen mRNA levels without affecting alpha1(I) procollagen protein levels, confirming a post-transcriptional site for regulatory control by amino acid deprivation. In the absence of ascorbic acid, alpha1(I) procollagen protein levels increased in amino acid deprived fibroblasts, but alpha1(I) procollagen mRNA levels were not affected. The absence of ascorbic acid likely resulted in the accumulation of nonhelical procollagen in the endoplasmic reticulum, indicating that translational mechanisms for alpha1(I) procollagen were intact. The addition of chloroquine, an inhibitor of lysosomal degradation of proteins, increased alpha1(I) procollagen protein levels in amino acid deprived fibroblasts. These data suggest that following amino acid deprivation of quiescent fibroblasts, newly synthesized type I collagen was degraded intracellularly, primarily by a process that involved lysosomal proteinases.
Collapse
Affiliation(s)
- D C Rishikof
- The Pulmonary Center and the Department of Biochemistry at the Boston University School of Medicine and the Boston VA Medical Center, Boston, Massachusetts 02118,
| | | | | | | |
Collapse
|